Co-Diagnostics, Inc.
General ticker "CODX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $7.4M (TTM average)
Co-Diagnostics, Inc. does not follow the US Stock Market performance with the rate: -19.0%.
Estimated limits based on current volatility of 4.2%: low 1.17$, high 1.28$
Factors to consider:
- Total employees count: 115 (-12.9%) as of 2025
- US accounted for 72.1% of revenue in the fiscal year ended 2022-12-31
- Top business risk factors: Limited operating history, Inability to achieve profitability, Regulatory and compliance, Market competition, Supply chain disruptions
- Current price 77.3% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.12$, 13.75$]
- 2026-12-31 to 2027-12-31 estimated range: [3.63$, 10.23$]
Financial Metrics affecting the CODX estimates:
- Negative: with PPE of -0.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -328.26 <= 0.28
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of 296.00 > -0.64
Short-term CODX quotes
Long-term CODX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $6.81MM | $3.92MM | $0.62MM |
| Operating Expenses | $49.52MM | $44.00MM | $50.79MM |
| Operating Income | $-42.71MM | $-40.08MM | $-50.17MM |
| Non-Operating Income | $4.60MM | $2.50MM | $1.65MM |
| R&D Expense | $22.96MM | $20.98MM | $19.14MM |
| Income(Loss) | $-38.11MM | $-37.58MM | $-48.51MM |
| Taxes | $-2.78MM | $0.06MM | $-1.62MM |
| Net Income(Loss)* | $-35.33MM | $-37.64MM | $-46.90MM |
| Stockholders Equity | $86.01MM | $54.31MM | $20.63MM |
| Inventory | $1.66MM | $1.07MM | $0.99MM |
| Assets | $95.32MM | $64.00MM | $24.74MM |
| Operating Cash Flow | $-22.08MM | $-29.16MM | $-29.14MM |
| Capital expenditure | $1.37MM | $0.75MM | $0.70MM |
| Investing Cash Flow | $15.39MM | $17.07MM | $26.27MM |
| Financing Cash Flow | $-1.36MM | $0.10MM | $11.81MM |
| Earnings Per Share** | $-36.12 | $-37.22 | $-35.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.